Trump’s new rule on prescriptions will send the cost of my drugs through the roof — and maybe yours too

New restrictions set to take effect will severely limit Americans' ability to import personal prescription medications, particularly from Canadian pharmacies, under tightened FDA and Customs enforcement. The policy shift, driven by concerns over counterfeit drugs and safety risks, threatens to disrupt access for millions who rely on lower-cost alternatives. Critics argue the move prioritizes protectionism over affordability, potentially forcing consumers to pay significantly higher prices domestically. The crackdown marks a major change in cross-border pharmaceutical trade, raising questions about patient access and regulatory oversight.

President Trump’s protectionism gives Americans the same “protection” that the wolf gave to the lamb.  The Food and Drug Administration and Customs Border Protection will effectively ban almost all personal prescription imports in January. Millions of Americans who rely on Canadian pharmacies will be whipsawed by much higher prices. The new policy is spurred by...